Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer

SIMPLE SUMMARY: The development of drug resistance in HER2 targeted therapies poses a major challenge in breast cancer treatment. To address this challenge, researchers have adopted two main strategies: repurposing existing drugs to enhance their effectiveness and identifying new targets to broaden...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yi, Li, Yunjin, Liu, Ruijie, Zhou, Jianhua, Wang, Kuansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177527/
https://www.ncbi.nlm.nih.gov/pubmed/37174034
http://dx.doi.org/10.3390/cancers15092568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177527/
https://www.ncbi.nlm.nih.gov/pubmed/37174034
http://dx.doi.org/10.3390/cancers15092568

Ejemplares similares